Sinusitis & rhinitis — all decisions

The Board granted service connection for a cervical spine condition and dismissed the claim for PTSD, while denying claims for radiculopathy of the right upper extremity, TBI rating increase, status post right knee meniscectomy rating increase, and scar rating.

The Board granted an effective date of August 14, 2022, for service connection for sinusitis and allergic rhinitis but denied increased ratings for both conditions.

The Board denied an effective date prior to June 17, 2022, for the award of service connection for migraine headaches and an initial rating in excess of 30 percent for migraine headaches. The claim for a compensable rating for chronic sinusitis was remanded.

The Board denied service connection for chronic sinusitis, hyperlipidemia, diabetes mellitus, type II, diabetic retinopathy, erectile dysfunction, kidney cancer, and coronary artery disease.

The Board denied an initial rating in excess of 10 percent for allergic rhinitis and remanded the issue of entitlement to service connection for coronary artery disease.

The Board denied the veteran's claims for increased ratings and service connection, finding that the evidence did not support higher disability ratings or service connection.

The Board denied service connection for chronic fatigue syndrome, sinusitis, and sleep apnea but granted service connection for bilateral ankle strain and bilateral knee strain. The claims for increased ratings were also denied.

The Board denied the veteran's claims for earlier effective dates and increased ratings, as well as service connection for rhinitis, higher ratings for lumbar spine disability and left lower extremity radiculopathy, and a TDIU.

The Board granted service connection for headaches, right and left ankle disabilities, sinusitis, rhinitis, and irritable bowel syndrome, and granted an initial disability rating of 30 percent for the Veteran's service-connected headaches.

The Veteran's bilateral hearing loss is granted, while a rating in excess of 10 percent for tinnitus is denied. Several service connection claims are remanded.

The Board denied service connection for chronic fatigue syndrome and allergic rhinitis, granted service connection for obstructive sleep apnea, and denied an initial compensable rating for tension headaches. The claim for erectile dysfunction was remanded.

The Board denied service connection for chronic sinusitis and an initial compensable rating for allergic rhinitis from August 10, 2022.

The Board denied service connection for various conditions, including tinnitus, an acquired psychiatric disability, memory loss, Persian Gulf Veteran with a qualifying chronic disability, right foot disability, sleep apnea, dental disability (loose teeth) for compensation purposes, sinusitis, muscle pain in whole body, and stomach disability. The effective date for the grant of service connection for tinnitus was denied as earlier than December 1, 2023.

The appeal for an initial compensable evaluation for allergic rhinitis was dismissed due to the Veteran's explicit and unambiguous withdrawal of the appeal.

The Board has dismissed all appeals for service connection and a rating in excess of 10 percent for rhinitis.

The Board remands the claims for an increased evaluation of a lumbar spine disability, service connection for migraines and chronic sinusitis due to deficiencies in the VA examinations.

The Board remands the claim for service connection for allergic rhinitis to correct pre-decisional duty to assist errors and obtain a supplemental medical opinion.

The Board remands the claim for a compensable rating for allergic rhinitis to obtain an addendum opinion regarding the ameliorative effects of medication on the severity of the disability.

The Board denied the Veteran's claim for service connection for allergic rhinitis due to a lack of evidence showing a current diagnosis.

The Board granted service connection for rhinosinusitis with nasal polyps on a presumptive basis due to presumed exposure to fine particulate matter during active service in Southwest Asia. The claims for sleep apnea syndrome and degenerative joint disease of the lumbar spine were remanded for further development.